Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.63 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.63 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.55 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 2/20 | 0.53 |
| ▸ | SRC | P12931 | 2/20 | 0.51 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.51 |
| ▸ | GAK | O14976 | 1/20 | 0.51 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.51 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.51 |
| ▸ | ABL1 | P00519 | 1/20 | 0.51 |
| ▸ | LCK | P06239 | 1/20 | 0.51 |
| ▸ | EPHA1 | P21709 | 1/20 | 0.51 |
| ▸ | EPHA8 | P29322 | 1/20 | 0.51 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.51 |
| ▸ | MAP2K5 | Q13163 | 1/20 | 0.51 |
| ▸ | COQ8A | Q8NI60 | 1/20 | 0.51 |
| ▸ | NLK | Q9UBE8 | 1/20 | 0.51 |
| ▸ | KDR | P35968 | 1/20 | 0.51 |
| ▸ | NCF1 | P14598 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amiquinsin SCHEMBL30616015 | 0.98 | EHMT2 (0.61) | EHMT2EHMT1PDGFRBPDGFRAEGFR | |
| Amiquinsin SCHEMBL122139 | 0.96 | EHMT2 (0.60) | EHMT2EHMT1PDGFRBPDGFRAEGFR | |
| Amiquinsin SCHEMBL27533387 | 0.88 | EHMT2 (0.53) | EHMT2EHMT1PDGFRBPDGFRAEGFR | |
| SCHEMBL4400367 | 0.84 | PDGFRB (0.72) | PDGFRBPDGFRAEGFRSRCFGFR2 | |
| Amiquinsin SCHEMBL31187496 | 0.82 | EHMT2 (0.47) | EHMT2EHMT1PDGFRBPDGFRAEGFR | |
| SCHEMBL29736268 | 0.82 | EHMT2 (0.60) | EHMT2EHMT1EGFRGAKKDR | |
| SCHEMBL1496287 | 0.79 | PDGFRB (0.57) | PDGFRBPDGFRAEGFRSRCBMPR1B | |
| SCHEMBL4480466 | 0.79 | PDGFRB (0.61) | PDGFRBPDGFRAEGFRSRCKDR | |
| SCHEMBL29079702 | 0.79 | PDGFRB (0.60) | PDGFRBPDGFRAEGFRSRCFGFR2 | |
| SCHEMBL30574469 | 0.79 | PDGFRB (0.60) | PDGFRBPDGFRAEGFRSRCFGFR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-4868182-A | HYPOTENSIVE AND CARDIOTONIC, SYNERGISTIC | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-09-19 | — | — | US | claimed |
| WO-2024194756-A1 | MODULATING THE INNATE IMMUNITY OF RNA | PFIZER INC. (US) | 2024-09-26 | — | — | WO | disclosed |
| CN-114957136-A | Anti-tumor compound used as VEGFR inhibitor and application thereof | 南京科默生物医药有限公司 | 2022-08-30 | — | — | CN | disclosed |
| US-20220047505-A1 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | STI PHARMA, LLC (US) | 2022-02-17 | — | — | US | disclosed |
| US-11191719-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2021-12-07 | — | — | US | disclosed |
| US-10463611-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2019-11-05 | — | — | US | disclosed |
| WO-2019177971-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP-1) INHIBITORS AND USES THEREOF | MAVUPHARMA, INC. (US) | 2019-09-19 | — | — | WO | disclosed |
| US-4686228-A | Quinoline therapeutic agents | PFIZER INC. (US) | 1987-08-11 | — | — | US | disclosed |
| EP-0100200-B1 | 2-SUBSTITUTED 4-AMINO-6,7-DIMETHOXYQUINOLINES | Pfizer Limited (GB) | 1987-05-06 | — | — | EP | disclosed |
| EP-0100200-B1 | 2-SUBSTITUTED 4-AMINO-6,7-DIMETHOXYQUINOLINES | Pfizer Limited (GB) | 1987-05-06 | — | — | EP | disclosed |
| US-4656174-A | HYPOTENSIVE AGENTS | PFIZER INC. (US) | 1987-04-07 | — | — | US | disclosed |
| EP-0100200-A1 | 2-Substituted 4-amino-6,7-dimethoxyquinolines | Pfizer Limited (GB) | 1984-02-08 | — | — | EP | disclosed |
| EP-0100200-A1 | 2-Substituted 4-amino-6,7-dimethoxyquinolines | Pfizer Limited (GB) | 1984-02-08 | — | — | EP | disclosed |
| EP-0100200-A1 | 2-Substituted 4-amino-6,7-dimethoxyquinolines | Pfizer Limited (GB) | 1984-02-08 | — | — | EP | disclosed |